This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Ovarian Cancer
  • /
  • Veliparib in ovarian cancer: a new synthetically l...

Veliparib in ovarian cancer: a new synthetically lethal therapeutic approach

Read time: 1 mins
Published:1st Feb 2020
Author: Boussios S, Karihtala P, Moschetta M, Abson C, Karathanasi A, Zakynthinakis-Kyriakou N et al.
Availability: Pay for access, or by subscription
Ref.:Invest New Drugs. 2020 Feb;38(1):181-193.
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest